Neurosarcoidosis-like reaction under TNF-α inhibitors: a case report and literature review of a paradoxical immune phenomenon. [PDF]
Barbella G +4 more
europepmc +1 more source
Non-Responders to Biologic Disease Modifying Antirheumatic Treatment for Inflammatory Bowel Diseases. [PDF]
Gadzhanova S, Roughead E.
europepmc +1 more source
A meta‐analysis was conducted comparing the efficacy of biologics for the treatment of hidradenitis suppurativa (HS) for 12–16 weeks. Based on the SUCRA, bimekizumab was ranked the most efficacious treatment compared with secukinumab and adalimumab for all assessed efficacy outcomes, positioning it as the best treatment across biologic‐naïve and ...
Haley B. Naik +9 more
wiley +1 more source
Mid-childhood acne conglobata successfully treated with adalimumab. [PDF]
Vidal González A +5 more
europepmc +1 more source
Severe, Resistant Generalized Pustular Psoriasis-Associated Inflammatory Syndrome Successfully Treated With Adalimumab: A Case Report. [PDF]
Bourousis E, Kotzamani MT, Maritsi DN.
europepmc +1 more source
Savings from biosimilars and Medicare formulary access. [PDF]
Axelsen K, Courmier D, Bai G, Maini L.
europepmc +1 more source
Retrieval Augmented Generation (RAG) for Evaluating Regulatory Compliance of Drug Information and Clinical Trial Protocols. [PDF]
Waikar S, Bhat AG, Ramanathan M.
europepmc +1 more source
Engagement and retention with remote monitoring in psoriasis: Findings from the mySkin study
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page e274-e277, April 2026.
Weiyu Ye +22 more
wiley +1 more source
Long‐term safety and efficacy in paediatric psoriasis: Remaining challenges
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page 558-559, April 2026.
Catherine Droitcourt, Ninon Le Goaziou
wiley +1 more source

